Creatine kinase-MB does not add additional benefit to a negative troponin in the evaluation of chest pain. Am J Emerg Med. 2012;30:188 90. 162. Newby LK, Roe MT, Chen AY, et al. Frequency and clinical implications of discordant creatine kinase-MB and troponin measurements in acute coronary syndromes. J Am Coll Cardiol. 2006;47:312 8. 163. Kavsak PA, MacRae AR, Newman AM, et al. Effects of contemporary troponin assay sensitivity on the utility of the early markers myoglobin and CKMB isoforms in evaluating patients with possible acute myocar- dial infarction. Clin Chim Acta. 2007;380:213 6. 164. Giannitsis E, Steen H, Kurz K, et al. Cardiac magnetic resonance imag- ing study for quantification of infarct size comparing directly serial ver- sus single time-point measurements of cardiac troponin T. J Am Coll Cardiol. 2008;51:307 14. 165. Younger JF, Plein S, Barth J, et al. Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of micro- vascular obstruction. Heart. 2007;93:1547 51. 166. Bonaca M, Scirica B, Sabatine M, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol. 2010;55:2118 24. 167. de Lemos JA, Morrow DA, Bentley JH, et al. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med. 2001;345:1014 21. 168. Weber M, Bazzino O, Navarro Estrada JL, et al. N-terminal B-type natri- uretic peptide assessment provides incremental prognostic information in patients with acute coronary syndromes and normal troponin T values upon admission. J Am Coll Cardiol. 2008;51:1188 95. 169. Heeschen C, Hamm CW, Bruemmer J, et al. Predictive value of C-reactive protein and troponin T in patients with unstable angina: a comparative analysis. CAPTURE Investigators. Chimeric c7E3 AntiPlatelet Therapy in Unstable angina REfractory to standard treatment trial. 